Skip to main content
logo
Adaptimmune Therapeutics plc (MUN:473A)
Germany flag Germany · Delayed Price · Currency is EUR
0.0160
0.00 (0.00%)
Last updated: Jun 2, 2026, 8:00 AM CET

Adaptimmune Therapeutics Revenue

In the year 2025, Adaptimmune Therapeutics had annual revenue of $5.92M USD, down -96.67%.

Revenue
$5.92M
Revenue Growth
-96.62%
P/S Ratio
1.26
Revenue / Employee
$11.71K
Employees
506
Market Cap
6.37M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.92M-172.11M-96.67%
Dec 31, 2024178.03M117.75M195.34%
Dec 31, 202360.28M33.13M122.05%
Dec 31, 202227.15M21.00M341.50%
Dec 31, 20216.15M2.19M55.36%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biotest GmbH & Co. KGaA635.20M
Darwin AG54.30M
Paion AG14.81M
2invest AG8.89M
MagForce AG1.08M
Biomark Diagnostics57.01K
co.don AG22.00K
bioXXmed AG20.49K
Revenue Rankings

Adaptimmune Therapeutics News

More News